Moderna stock surges 17% on coronavirus vaccine trial news
July 14, 2020 at 17:41 PM EDT
Trial vaccine elicits ‘robust’ immune-system response in larger group of people, Moderna said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|